ConductScience.org, home

Paper28086993

Lack of partial renal response by 12 weeks after induction therapy predicts poor renal response and systemic damage accrual in lupus nephritis class III or IV.

Hanaoka H and 13 others. Arthritis Res Ther, 2017. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Lack of partial renal response by 12 weeks after induction therapy predicts poor renal response and systemic damage accrual in lupus nephritis class III or IV. Papers, record 28086993. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28086993

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lack of partial renal response by 12 weeks after induction therapy predicts poor renal response and systemic damage accrual in lupus nephritis class III or IV.
PubMed
Journal
Arthritis Res Ther
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
1.05
iCite
Revised in PubMed
2018-11-13
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hanaoka HHironari
2Yamada HHidehiro
3Kiyokawa TTomofumi
4Iida HHarunobu
5Suzuki TTakeshi
6Yamasaki YYoshioki
7Ooka SSeido
8Nagafuchi HHiroko
9Okazaki TTakahiro
10Ichikawa DDaisuke
11Shirai SSayuri
12Shibagaki YYugo
13Koike JJunki
14Ozaki SShoichi

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immunosuppressive AgentsMajor topic
Lupus NephritisMajor topic
Adult
Female
Humans
Induction Chemotherapy
Male
Middle Aged
Prognosis
Remission Induction
Retrospective Studies
Treatment Outcome

Source PubMed

Download CSV of topics

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19324032Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum1997https://conductscience.org/library/papers/9324032PubMed
212966597Accrual of organ damage over time in patients with systemic lupus erythematosus.J Rheumatol2003https://conductscience.org/library/papers/12966597PubMed
325757867Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis.Ann Rheum Dis2016https://conductscience.org/library/papers/25757867PubMed
415334470Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.Arthritis Rheum2004https://conductscience.org/library/papers/15334470PubMed
517265497Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort.Arthritis Rheum2007https://conductscience.org/library/papers/17265497PubMed
6835580Lupus nephritis. Clinical course as related to morphologic forms and their transitions.Am J Med1977https://conductscience.org/library/papers/835580PubMed
78607884The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.Arthritis Rheum1996https://conductscience.org/library/papers/8607884PubMed
822129255Systemic lupus erythematosus.N Engl J Med2011https://conductscience.org/library/papers/22129255PubMed
919369404Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.J Am Soc Nephrol2009https://conductscience.org/library/papers/19369404PubMed
101599520Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.Arthritis Rheum1992https://conductscience.org/library/papers/1599520PubMed
111251849The bimodal mortality pattern of systemic lupus erythematosus.Am J Med1976https://conductscience.org/library/papers/1251849PubMed
1222851469
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.
Ann Rheum Dis2012https://conductscience.org/library/papers/22851469PubMed
13309095Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide.N Engl J Med1978https://conductscience.org/library/papers/309095PubMed
1425861455Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus-the Hopkins Lupus Cohort.Lupus Sci Med2015https://conductscience.org/library/papers/25861455PubMed
1510743809Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.J Rheumatol2000https://conductscience.org/library/papers/10743809PubMed
1611237132Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus.Lupus2001https://conductscience.org/library/papers/11237132PubMed
1719208608Prednisone, lupus activity, and permanent organ damage.J Rheumatol2009https://conductscience.org/library/papers/19208608PubMed
1824739325Treat-to-target in systemic lupus erythematosus: recommendations from an international task force.Ann Rheum Dis2014https://conductscience.org/library/papers/24739325PubMed
1918003764Value of a complete or partial remission in severe lupus nephritis.Clin J Am Soc Nephrol2008https://conductscience.org/library/papers/18003764PubMed
2020131293Selective blockade of BAFF for the prevention and treatment of systemic lupus erythematosus nephritis in NZM2410 mice.Arthritis Rheum2010https://conductscience.org/library/papers/20131293PubMed

See all 25 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
41898159Clinical and Biochemical Factors Associated with Delayed Renal Response in Proliferative Lupus Nephritis: A 20-Year Single-Center Multiethnic Cohort Study.Biomedicines2026https://conductscience.org/library/papers/41898159PubMed
38940925Efficacy and safety of belimumab combined with the standard regimen in treating children with lupus nephritis.Eur J Pediatr2024https://conductscience.org/library/papers/38940925PubMed
37452914Flares in Lupus Nephritis: Risk Factors and Strategies for Their Prevention.Curr Rheumatol Rep2023https://conductscience.org/library/papers/37452914PubMed
36255555Management and outcomes in children with lupus nephritis in the developing countries.Pediatr Nephrol2023https://conductscience.org/library/papers/36255555PubMed
36078950Predictors of Early Response, Flares, and Long-Term Adverse Renal Outcomes in Proliferative Lupus Nephritis: A 100-Month Median Follow-Up of an Inception Cohort.J Clin Med2022https://conductscience.org/library/papers/36078950PubMed
35854166Renal response and its predictive factors of lupus nephritis: a 2-year real-world study of 56 hospital-based patients.Clin Rheumatol2022https://conductscience.org/library/papers/35854166PubMed
35498799What Have We Learnt About the Treatment of Juvenile-Onset Systemic Lupus Erythematous Since Development of the SHARE Recommendations 2012?Front Pediatr2022https://conductscience.org/library/papers/35498799PubMed
34636151Comparison of renal remission and relapse-free rate in initial- and delayed-onset lupus nephritis.Int J Rheum Dis2021https://conductscience.org/library/papers/34636151PubMed
32500443An Update on the Diagnosis and Management of Lupus Nephritis.Curr Rheumatol Rep2020https://conductscience.org/library/papers/32500443PubMed
31296139Delayed lupus nephritis in the course of systemic lupus erythematosus is associated with a poorer treatment response: a multicentre, retrospective cohort study in Japan.Lupus2019https://conductscience.org/library/papers/31296139PubMed
30159624Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus.Pediatr Nephrol2019https://conductscience.org/library/papers/30159624PubMed
29720229Early achievement of deep remission predicts low incidence of renal flare in lupus nephritis class III or IV.Arthritis Res Ther2018https://conductscience.org/library/papers/29720229PubMed
28982696Calcineurin Inhibitors in the Treatment of Lupus Nephritis: A Hare Versus Turtle Story?J Am Soc Nephrol2017https://conductscience.org/library/papers/28982696PubMed
28384208Comparison of renal response to four different induction therapies in Japanese patients with lupus nephritis class III or IV: A single-centre retrospective study.PLoS One2017https://conductscience.org/library/papers/28384208PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
C1QA712PubTator's text mininghttps://conductscience.org/library/genes/712NCBI Gene
CD79A973PubTator's text mininghttps://conductscience.org/library/genes/973NCBI Gene
FGB2244PubTator's text mininghttps://conductscience.org/library/genes/2244NCBI Gene
PGR5241PubTator's text mininghttps://conductscience.org/library/genes/5241NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28086993

GET https://conductscience.org/api/papers/v1/28086993/references?page=2